Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.64 |
| ▸ | SRD5A2 | P31213 | 4/20 | 0.62 |
| ▸ | PTPRC | P08575 | 4/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.59 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.59 |
| ▸ | FEN1 | P39748 | 1/20 | 0.59 |
| ▸ | CES2 | O00748 | 2/20 | 0.53 |
| ▸ | CES1 | P23141 | 2/20 | 0.53 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.53 |
| ▸ | LTA4H | P09960 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | CPT1B | Q92523 | 1/20 | 0.52 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.52 |
| ▸ | BAX | Q07812 | 1/20 | 0.52 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.52 |
| ▸ | PGR | P06401 | 1/20 | 0.52 |
| ▸ | PTPRF | P10586 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4189871 | 0.91 | PARP10 (0.69) | PARP10SRD5A2ERCC5FEN1CES2 | |
| SCHEMBL9043928 | 0.89 | PKM (0.66) | PARP10SRD5A2PTPRCPTPN1ERCC5 | |
| SCHEMBL9242631 | 0.89 | CES2 (0.68) | PARP10SRD5A2ERCC5FEN1CES2 | |
| SCHEMBL9807208 | 0.87 | PARP10 (0.64) | PARP10SRD5A2ERCC5FEN1CES2 | |
| SCHEMBL2134251 | 0.86 | CES2 (0.71) | PARP10SRD5A2ERCC5FEN1CES2 | |
| SCHEMBL13567254 | 0.86 | CES2 (0.71) | PARP10SRD5A2ERCC5FEN1CES2 | |
| SCHEMBL9250736 | 0.86 | CES2 (0.71) | PARP10SRD5A2ERCC5FEN1CES2 | |
| SCHEMBL28800035 | 0.84 | PARP10 (0.56) | PARP10SRD5A2ERCC5FEN1CES2 | |
| SCHEMBL15059492 | 0.83 | PARP10 (0.60) | PARP10SRD5A2ERCC5FEN1CES2 | |
| SCHEMBL8366994 | 0.83 | PARP10 (0.60) | PARP10SRD5A2ERCC5FEN1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115403459-A | Preparation method of 1, 4-dicarbonyl compound | 广州自远生物科技有限公司 | 2022-11-29 | — | — | CN | disclosed |
| US-20100022676-A1 | PHOTOCURABLE COMPOSITIONS COMPRISING A PHOTOINITIATOR OF THE PHENYLGLYOXYLATE TYPE | CIBA CORPORATION | 2010-01-28 | — | — | US | disclosed |
| US-20090075989-A1 | NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS | BAYER SCHERING PHARMA AG (DE) | 2009-03-19 | — | — | US | disclosed |
| US-20090075989-A1 | NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS | BAYER SCHERING PHARMA AG (DE) | 2009-03-19 | — | — | US | disclosed |
| US-20090075989-A1 | NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS | BAYER SCHERING PHARMA AG (DE) | 2009-03-19 | — | — | US | disclosed |
| US-7396488-B2 | Light emitting device and fluorescent material | MITSUBISHI CHEMICAL CORPORATION (JP) | 2008-07-08 | — | — | US | disclosed |
| US-7396488-B2 | Light emitting device and fluorescent material | MITSUBISHI CHEMICAL CORPORATION (JP) | 2008-07-08 | — | — | US | disclosed |
| WO-2008077646-A1 | NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-07-03 | — | — | WO | disclosed |
| WO-2008077646-A1 | NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-07-03 | — | — | WO | disclosed |
| WO-2008040650-A2 | PHOTOCURABLE COMPOSITIONS COMPRISING A PHOTOINITIATOR OF THE PHENYLGLYOXYLATE TYPE | CIBA HOLDING INC. (CH) | 2008-04-10 | — | — | WO | disclosed |
| CN-1244666-C | Fluorescent maleimides and uses thereof | CIBA SC HOLDING AG (CH) | 2006-03-08 | — | — | CN | disclosed |
| CN-1721498-A | Fluorescent maleimides and uses thereof | CIBA SC HOLDING AG (CH) | 2006-01-18 | — | — | CN | disclosed |
| US-6960667-B2 | Fluorescent maleimides and uses thereof | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2005-11-01 | — | — | US | disclosed |
| US-20030189191-A1 | Fluorescent maleimides and uses thereof | KUNIMOTO KAZUHIKO (JP) | 2003-10-09 | — | — | US | disclosed |
| US-6508957-B2 | Ultraviolet fluorescent material for void detection and for preparation of scintillators, films, luminescent solar energy collectors, organic electroluminescent devices, printing inks, electrophotographic toners | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-01-21 | — | — | US | disclosed |
| CN-1374995-A | Fluorescent maleimides and uses thereof | CIBA SC HOLDING AG (CH) | 2002-10-16 | — | — | CN | disclosed |
| EP-1216285-A1 | FLUORESCENT MALEIMIDES AND USES THEREOF | Ciba SC Holding AG (CH) | 2002-06-26 | — | — | EP | disclosed |
| US-20020065422-A1 | Fluorescent maleimides and uses thereof | KUNIMOTO KAZUHIKO (JP) | 2002-05-30 | — | — | US | disclosed |
| US-6258954-B1 | ELECTROLUMINESCENCE; DETECTION VOIDS | CIBA SPECIALTY CHEMICALS CORP. | 2001-07-10 | — | — | US | disclosed |
| WO-2001019939-A1 | FLUORESCENT MALEIMIDES AND USES THEREOF | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2001-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020065422-A1 | Fluorescent maleimides and uses thereof | IK, PAH, MYO1F | PARP10 1103/4885SRD5A2 367/4885PTPRC 1951/4885 |
| US-20030189191-A1 | Fluorescent maleimides and uses thereof | CBR1, CBR3, MT-CO2 | PARP10 1435/4885SRD5A2 508/4885PTPRC 2664/4885 |
| US-20100022676-A1 | PHOTOCURABLE COMPOSITIONS COMPRISING A PHOTOINITIATOR OF THE PHENYLGLYOXYLATE TYPE | GLO1, HPD, GRHPR | PARP10 497/4885SRD5A2 3152/4885PTPRC 3186/4885 |
| US-20090075989-A1 | NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS | NR5A1, CYP19A1, GPER1 | PARP10 1431/4885SRD5A2 27/4885PTPRC 2383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.